Related Experiment Video
Updated: Dec 22, 2025

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Extracellular vesicle-associated lipids in central nervous system disorders
Sam Vanherle1, Mansour Haidar1, Joy Irobi1
1Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Lipid metabolism changes in extracellular vesicles (EVs) are linked to central nervous system (CNS) disorders. Modulating EV lipids may offer new therapies and diagnostic markers for diseases like Alzheimer's.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Lipid metabolism is altered in central nervous system (CNS) disorders, including multiple sclerosis, Alzheimer's, and Parkinson's disease.
- Extracellular vesicles (EVs) are crucial for intercellular communication and homeostasis, transporting various lipid species.
- Changes in the EV lipidome correlate with disease progression and remission in CNS disorders.
Purpose of the Study:
- To review and discuss alterations in the EV lipidome in CNS disorders.
- To elaborate on the impact of EV-associated lipids on pathological processes.
- To explore the therapeutic and diagnostic potential of EV lipids.
Main Methods:
- Literature review and synthesis of existing studies on EV lipidomics in CNS disorders.
- Analysis of the role of specific EV-associated lipids in neuroinflammation, repair, and protein aggregation.
- Discussion of therapeutic strategies targeting the EV lipidome.
Main Results:
- EV-associated lipids are significantly altered in CNS disorders.
- These lipids influence neuroinflammation, CNS repair mechanisms, and pathological protein aggregation.
- Specific EV lipid signatures are associated with disease stages.
Conclusions:
- EV-associated lipids play a critical role in the pathophysiology of CNS disorders.
- Modulating the EV lipidome presents a promising therapeutic avenue for multiple sclerosis, Alzheimer's, and Parkinson's disease.
- EV lipid signatures hold potential as diagnostic and early detection biomarkers for CNS disorders.
More Related Videos
10:09Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
06:58Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
Related Concept Videos
Intralumenal Vesicles and Multivesicular Bodies
Lysosomal Hydrolases
Fusion of Secretory Vesicles with the Plasma Membrane
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...